DEF: AMREP Sets 2025 Annual Meeting Agenda, Board Nominee
Proxy Statement
AMREP Corporation announces its 2025 Annual Meeting of Shareholders to address director election, executive compensation, and auditor ratification.
Summary
- The 2025 Annual Meeting of Shareholders for AMREP Corporation will be held on September 11, 2025, at 9:00 A.M. Eastern Time in Newtown Square, Pennsylvania.
- Shareholders will vote on four key proposals: the election of one Class II director, an advisory vote on named executive officer compensation, an advisory vote on the frequency of future executive compensation votes, and the ratification of Rosenberg Rich Baker Berman, P.A. as the independent registered public accounting firm for fiscal year 2026.
- The Board of Directors unanimously recommends voting 'For' the election of Robert E. Robotti as director, 'For' the approval of named executive officer compensation, 'For' a 'One Year' frequency for future advisory votes on executive compensation, and 'For' the ratification of the accounting firm.
- The record date for shareholders entitled to vote at the meeting is July 21, 2025.
- As of July 21, 2025, the company had 5,305,949 shares of common stock issued and outstanding.
- Net income for fiscal year 2025 was $12,716,000, compared to $6,690,000 in 2024 and $21,790,000 in 2023.
- Total Shareholder Return (TSR) for an initial $100 investment was $175.35 in 2025, $157.73 in 2024, and $108.09 in 2023, based on closing stock prices of $22.55 (2025), $20.28 (2024), and $13.90 (2023).
- The company dismissed Baker Tilly US, LLP as its independent registered public accounting firm on July 24, 2024, and engaged Rosenberg Rich Baker Berman, P.A. on the same date; no disagreements or reportable events were noted with the former auditor.
Sentiment
Score: 6
Explanation: The filing is a standard proxy statement, indicating routine corporate governance. Positive aspects include consistent TSR growth and a recovery in net income for the most recent fiscal year. Negatives include a significant prior year net income drop and subjective executive compensation practices. Overall, the tone is neutral and factual, typical for this type of regulatory document, with no major red flags or exceptionally positive news.
Positives
- The Board of Directors provides clear, unanimous recommendations for all proposals, indicating strong internal alignment.
- The company maintains robust corporate governance standards, including independent directors forming a majority of the board and key committees (Nominating and Corporate Governance, Audit, Compensation and Human Resources) composed entirely of independent directors.
- The company has a clear insider trading policy that prohibits hedging or monetization transactions involving company securities, promoting compliance and aligning management interests with shareholders.
- All required Section 16(a) reports for directors, officers, and major shareholders were filed on a timely basis for 2025.
- Total Shareholder Return (TSR) has shown consistent positive growth, increasing from $108.09 in 2023 to $175.35 in 2025 for an initial $100 investment.
- Net income increased from $6,690,000 in 2024 to $12,716,000 in 2025, indicating a recovery in profitability.
Negatives
- Net income significantly decreased from $21,790,000 in 2023 to $6,690,000 in 2024, representing a substantial decline in profitability during that period.
- The company's compensation decisions for executive salaries are subjective and not based on a specific list of criteria, which could lead to less transparent or objective compensation practices.
- The company does not have a formal policy or practice regarding the timing of equity awards in relation to the disclosure of material nonpublic information, which could raise concerns about potential opportunistic timing.
Risks
- The company's compensation policies and practices for employees are evaluated to ensure they do not create incentives that could reasonably be expected to affect the risks faced by the company and its management, though no material adverse effect is currently expected.
- The Board's discretion to leave a director position vacant if a nominee is unwilling or unable to serve could lead to temporary gaps in board composition.
- Shareholder advisory votes on executive compensation and frequency are non-binding, meaning the Board is not obligated to follow shareholder preferences, which could lead to misalignment between shareholders and management on compensation matters.
Future Outlook
The filing primarily focuses on past performance and upcoming corporate governance matters for the 2025 Annual Meeting. It does not provide explicit forward-looking financial guidance or strategic outlook beyond the procedural aspects of the meeting and the Board's recommendations.
Management Comments
- The Board knows of no other matters that will be presented for consideration at the Annual Meeting beyond the four scheduled proposals.
- The Board believes that an annual advisory vote on executive compensation will allow shareholders to provide direct input on the company's compensation philosophy, policies, and practices every year.
- The Board believes that significant stock ownership by Board members further aligns their interests with the interests of the company's shareholders.
Industry Context
This proxy statement outlines standard corporate governance practices and executive compensation disclosures typical for a publicly traded company in the U.S. It reflects compliance with SEC regulations and NYSE corporate governance standards. The company's directors have diverse backgrounds, including real estate, investment management, and industrial sectors, suggesting a diversified business or investment focus, though the filing itself does not detail specific industry trends impacting the company's operations.
Comparison to Industry Standards
- The Compensation and Human Resources Committee states that its decisions regarding executive salaries are subjective and consider compensation at 'other companies' holding comparable positions, but no specific comparable companies, projects, or results are detailed in the filing.
- The company's adherence to NYSE Corporate Governance Standards, including independent director majority and independent committees, aligns with general best practices for U.S. listed companies.
- The stock ownership guideline for non-employee directors (30,000 shares within five years) is a common practice to align director interests with shareholders, though the specific target may vary across industries and company sizes.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Policy Adoption | The Board has adopted Corporate Governance Guidelines and a Code of Business Conduct and Ethics. | N/A | Enhances transparency and ethical conduct, aligning with NYSE Corporate Governance Standards. |
| Policy Adoption | The company has adopted an insider trading policy prohibiting hedging or monetization transactions involving company securities. | N/A | Promotes compliance with insider trading laws and aligns director/officer interests with shareholders. |
| Committee Composition | Nominating and Corporate Governance, Audit, and Compensation and Human Resources Committees are composed entirely of independent directors. | N/A | Ensures independent oversight in key governance areas, meeting NYSE requirements. |
| Board Practice | Non-management directors and independent directors meet in executive session at least twice per year. | N/A | Provides a forum for independent discussion without management presence, enhancing oversight. |
| Auditor Change | Dismissal of Baker Tilly US, LLP and engagement of Rosenberg Rich Baker Berman, P.A. as independent registered public accounting firm. | 2024-07-24 | Routine change in auditing firm; no disagreements or reportable events noted, suggesting a smooth transition. |
| Policy Adoption | Non-employee directors are expected to maintain ownership of at least 30,000 shares of Common Stock, with newly elected directors having five years to meet this guideline. | N/A | Aligns directors' financial interests with those of shareholders, promoting long-term value creation. |
Legal Proceedings
- As of July 31, 2025, there were no material pending legal proceedings to which any director, executive officer, or affiliate of the company, or any owner of more than five percent of the Common Stock, or any associate of any of the foregoing, was a party adverse to the company or its subsidiaries, or had a material interest adverse to the company or its subsidiaries.
Stakeholder Impact
- Shareholders: Will have the opportunity to vote on key governance matters, including director election, executive compensation, and auditor ratification, directly influencing the company's future direction and oversight.
- Employees: Executive compensation decisions and policies, including salary adjustments and equity awards, directly impact the company's leadership and potentially broader compensation philosophy.
- Management: The advisory votes on executive compensation and its frequency will provide feedback that the Board and Compensation Committee intend to consider for future compensation arrangements.
- Auditors: The ratification vote directly impacts the engagement of Rosenberg Rich Baker Berman, P.A. as the independent registered public accounting firm for fiscal year 2026.
Next Steps
- Shareholders to vote on director election, executive compensation, and auditor ratification at the Annual Meeting on September 11, 2025.
- The company will publish final voting results in a Current Report on Form 8-K after the Annual Meeting.
- The Board and its Compensation and Human Resources Committee intend to consider the results of the advisory vote on executive compensation in making future determinations.
- The Audit Committee will reconsider retaining Rosenberg Rich Baker Berman, P.A. if a majority of votes are against ratification, but is not obligated to select a new auditor.
- Shareholders intending to present proposals for the 2026 Annual Meeting must submit them by April 6, 2026, for inclusion in the proxy statement, or between May 14, 2026, and June 13, 2026, for advance notice.
Key Dates
| Date | Description |
|---|---|
| 1994 | Edward B. Cloues, II became a director of the Company. |
| 1996 | Albert V. Russo became a director of the Company. |
| 2016 | Robert E. Robotti became a director of the Company. |
| 2017 | Christopher V. Vitale became President and Chief Executive Officer of the Company. |
| 2021-07 | Christopher V. Vitale became a director of the Company. |
| 2021-11 | Company granted Mr. Vitale an option to purchase 50,000 shares of Common Stock and entered into an employment agreement with him. |
| 2022-04-30 | Fiscal year end for 2022 financial data. |
| 2023-04-30 | Fiscal year end for 2023 financial data. |
| 2024-04-30 | Fiscal year end for 2024 financial data. |
| 2024-05-17 | Amendment No. 6 filed jointly by James H. Dahl and Rainey E. Lancaster to Schedule 13D. |
| 2024-07-24 | Company dismissed Baker Tilly US, LLP as independent registered public accounting firm and engaged Rosenberg Rich Baker Berman, P.A. |
| 2024-07-25 | Company filed Current Report on Form 8-K regarding auditor change; Baker Tilly US, LLP's letter dated this date. |
| 2024-10-04 | Form 4 filed jointly by James H. Dahl and Rainey E. Lancaster. |
| 2025-04-30 | Fiscal year end for 2025 financial data and date for outstanding equity awards information. |
| 2025-07-17 | Audit Committee Report dated; Company approved new compensation for Mr. Vitale and Ms. Uleau. |
| 2025-07-21 | Record date for shareholders entitled to notice of and to vote at the Annual Meeting; date for beneficial ownership reporting. |
| 2025-07-25 | Annual Report on Form 10-K for fiscal year ended April 30, 2025, filed with the SEC. |
| 2025-07-28 | Effective date for new annual base salaries for Mr. Vitale and Ms. Uleau. |
| 2025-07-31 | Date as of which no material pending legal proceedings were reported. |
| 2025-08-04 | Date of the accompanying proxy statement and approximate date of first mailing to shareholders. |
| 2025-09-11 | Date of the 2025 Annual Meeting of Shareholders. |
| 2026-04-06 | Deadline for shareholder proposals to be included in the company's proxy statement for the 2026 Annual Meeting. |
| 2026-05-01 | Deadline for shareholder proposals to propose a candidate for selection as a nominee of the Board by the Nominating and Corporate Governance Committee for election at the 2026 Annual Meeting. |
| 2026-05-14 | Earliest date for the company's Secretary to receive advance notice of shareholder proposals not included in the proxy statement for the 2026 Annual Meeting. |
| 2026-06-13 | Latest date for the company's Secretary to receive advance notice of shareholder proposals not included in the proxy statement for the 2026 Annual Meeting. |
| 2026-07-12 | Vesting date for some restricted shares for Mr. Vitale and Ms. Uleau. |
| 2026-07-17 | Vesting date for some restricted shares for Mr. Vitale and Ms. Uleau. |
| 2026-07-18 | Vesting date for some restricted shares for Mr. Vitale and Ms. Uleau. |
| 2026-11-01 | Date Mr. Vitale's option to purchase 50,000 shares of Common Stock becomes exercisable. |
| 2027-07-17 | Vesting date for some restricted shares for Mr. Vitale and Ms. Uleau. |
| 2027-07-18 | Vesting date for some restricted shares for Mr. Vitale and Ms. Uleau. |
| 2028-07-17 | Vesting date for some restricted shares for Mr. Vitale and Ms. Uleau. |
| 2028 | Annual meeting of shareholders where the Class II director elected in 2025 will hold office until. |
| 2031-11-01 | Expiration date for Mr. Vitale's stock option. |
Keywords
Proxy Statement, Annual Meeting, Corporate Governance, Executive Compensation, Director Election, Auditor Ratification, Shareholder Vote, SEC Filing, Financial Reporting, Risk Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.